Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.
HealthDay News — Most U.S. adults have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, according to a survey released by the American Heart Association. The online survey included 4,007 U ...
Cardiovascular disease risk may be attributed to factors beyond changes in estrogen among women undergoing the menopause ...
A fully automated deep learning workflow for echocardiography in pulmonary arterial hypertension (PAH) is accurate and feasible.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback